Predictors of cerebral small-vessel disease in middle-aged, virologically-controlled people living with HIV

Clicks: 1
ID: 319159
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #193 of 208 articles by views in Open forum infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 208 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Background Despite durable viral suppression with antiretroviral therapy (ART), non-AIDS comorbidities remain frequent in aging people with HIV (PWH). Cerebral small-vessel disease (CSVD), a major contributor to stroke and cognitive decline, is up to twice as prevalent in middle-aged ART-treated PWH. Mechanisms underlying this excess risk remain unclear. Objective To identify inflammatory, viral, renal, and retinal vascular factors independently associated with CSVD in virologically-controlled PWH. Methods The case–control MicroBREAK-2 study (NCT02210130), nested in the PWH group of the MicroBREAK-1 study, included 80 ART-treated (≥5 years) PWH aged ≥50 years with MRI-defined CSVD and 80 matched CSVD-free controls (age ±5 years, sex, year of HIV diagnosis ±5 years). Participants underwent brain MRI, renal, carotid, and orbital color Doppler ultrasonography, and comprehensive ophthalmologic assessment. Circulating inflammatory and coagulation biomarkers, Epstein–Barr virus plasma load, and antiretroviral exposure were measured. Independent associations were identified using conditional logistic regression with LASSO selection and bootstrap resampling. Result Hypertension was the strongest independent correlate of CSVD (OR 4.92, 95% CI 1.23–19.62; p=0.02). Markers of persistent inflammatory and coagulative activity were also independently linked to CSVD, including higher white blood cell count (OR 1.58; 1.17–2.14; p=0.003) and elevated D-dimer levels (OR 1.52; 1.09–2.12; p=0.01). Increased intraocular pressure was independently related to CSVD (OR 6.37; 1.38–29.4; p=0.02). In contrast, HIV-specific parameters showed no independent relationship with CSVD. Conclusion In virologically-suppressed PWH, CSVD is primarily associated with hypertension and persistent low-grade inflammation rather than HIV-specific factors, underscoring the need for aggressive cardiovascular risk management.
Reference Key
openalex_W7166568472 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Antoine Moulignier, C. Lamirel, Arbnor Zenuni, P. Koskas, Corinne Amiel, Roland Tubiana, Christine Katlama, Soraya Fellahi, Jean‐Philippe Bastard, Jacqueline Capeau, Dominique Costagliola, Amélie Yavchitz, Augustin Lecler, L. Assoumou, for the Microvascular Brain Retina And Kidney (MicroBREAK) Study Group, A Moulignier, A Moulignier, C Amiel, L Assoumou, A Canestri, I Cochereau, J Capeau, D Costagliola, O Godin, PM Girard, C Katlama, C Lamirel, F-X Lescure, L Marchand, M Mazighi, M Obadia, M Paques, G Pialoux, E Plaisier, R Tubiana, N Valin, Y Yazdanpanah, P Yeni, A Moulignier, M Abrivard, A-S Alonso, I Cochereau, P Koskas, C Lamirel, L Lopes, M Mazighi, M Obadia, P Roux, J -C Sadik, L Salomon, J Savatovsky, V Vasseur, F-X Lescure, M Chansombat, R Landman, B Phung, D Rahli, Y Yazdanpanah, P Yeni, C Katlama, L Lenclume, R Tubiana, M Valantin, PM Girard, J -L Meynard, M Sebire, N Valin, G Pialoux, A Adda Liévin, C Amiel, Bastard Jp, A Canestri, J Capeau, S Fellahi, M -G Lebrette, E Plaisier, P Thibaut, D Costagliola, L Assoumou, G Dos Santos, O Godin, L Marchand, P Girard, J -P Vincensini
Journal Open forum infectious diseases
Year 2026
DOI
10.1093/ofid/ofag382
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.